Welcome to our dedicated page for Lemonade SEC filings (Ticker: LMND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lemonade, Inc. filings document operating results, governance, and capital-structure matters for its digital insurance business. Form 8-K reports furnish shareholder letters covering insurance operating metrics, financial condition, underwriting performance, profitability measures, and cash-flow disclosures.
The company's proxy materials address board and executive compensation matters, including equity-award and pay-versus-performance disclosures. Its SEC record also includes capital-structure and security-status filings related to warrants to purchase common stock, including exchange suspension, expiration, and Form 25 removal from listing and registration on NYSE American.
Lemonade, Inc. Chief Financial Officer Timothy E. Bixby reported an open-market sale of 73,000 shares of common stock on July 7, 2026 at a weighted average price of $79.18 per share. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026, meaning the sales were scheduled in advance. After these sales, Bixby directly holds 174,263 Lemonade shares. The filing notes the shares were sold in multiple trades between $76.03 and $81.13 per share.
Lemonade, Inc. Chief Insurance Officer John Sheldon Peters reported an open-market sale of common stock. On July 6, 2026, he sold 3,444 shares of Lemonade common stock at $79.00 per share. After this transaction, he directly holds 77,942 shares of common stock. The filing notes that this sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026, indicating the transaction was pre-scheduled rather than a discretionary trade.
LMND notice of proposed sale of 73,000 shares of Common Stock through Fidelity Brokerage Services LLC. The filing lists a total value of $5,780,452.92 and references 76,820,789 shares in the same line with the date 07/07/2026.
An earlier sale by Timothy E. Bixby of 2,227 shares for $118,416.72 is shown with a transaction date of 06/03/2026. The securities include restricted stock vesting dated 06/01/2017 described as Compensation.
LMND: A Rule 144 notice lists proposed sales of Common Stock, showing 3,444 shares identified under "Securities To Be Sold" with a 03/01/2025 vesting/compensation origin. The excerpt also records prior dispositions by John S. Peters: 1,735 shares sold on 06/03/2026 for $92,255.50 and 3,608 shares sold on 06/04/2026 for $191,007.52.
Lemonade, Inc. entered into a New Business Financing Agreement with Hannover Re (Ireland) DAC under which Hannover will provide up to $250 million of outstanding capital to finance sales and marketing growth from January 1, 2027 through December 31, 2028. The facility is subject to a maximum outstanding capital amount of $150 million from the funding begin date through December 31, 2027, and up to $250 million at any time from January 1, 2028 through December 31, 2028. At the start of each monthly growth period, Hannover may finance up to 80% of the company’s qualifying Growth Spend, not exceeding $20 million per reference cohort.
Repayments will be made from a specified percentage of premiums collected on customer cohorts linked to the funded spend, with a rate of return equal to the greater of 0% or the three-year U.S. Treasury Bill rate, plus 5.8%. Once a cohort is fully repaid, Lemonade retains all future premiums from that cohort. The agreement includes financial covenants, cancellation and commitment termination provisions, and standard representations and warranties, and remains in effect unless terminated under its terms.
Lemonade, Inc. director Michael A. Eisenberg reported a bona fide gift of 5,000 shares of common stock. The gift was made at a reported price of $0.00 per share and is a non-market transfer. After the gift, Eisenberg directly holds 195,452 common shares and has additional indirect interests through Aleph, L.P. and Aleph-Aleph, L.P., where he may share voting and investment power but disclaims beneficial ownership except for his pecuniary interest.
Lemonade, Inc. Chief Financial Officer Timothy E. Bixby reported a non-discretionary disposition of 2,227 shares of common stock on June 3, 2026 at $53.17 per share. According to the footnote, these shares were sold solely to cover tax withholding obligations tied to the vesting and settlement of Restricted Stock Units, rather than as a voluntary portfolio decision. After this transaction, Bixby directly holds 247,263 shares of Lemonade common stock.
Lemonade, Inc. Chief Insurance Officer John Sheldon Peters reported open-market sales of company common stock that were tied to equity compensation. He sold 1,735 shares on June 3 at $53.17 per share and 3,608 shares on June 4 at $52.94 per share, totaling 5,343 shares. After these transactions, he directly held 81,386 shares. A footnote explains that part of the activity represents shares sold to cover tax withholding obligations upon vesting of Restricted Stock Units and that sales were made pursuant to a Rule 10b5-1 trading plan, indicating these were pre-arranged, routine transactions rather than discretionary trades based on short-term market views.
Lemonade, Inc. insider Maya Prosor, Chief Business Officer, reported a small common stock transaction. On June 3, 2026, 1,220 shares of common stock were sold at $53.17 per share. According to the disclosure, this sale was not a discretionary transaction and reflects shares sold to cover tax withholding obligations tied to the vesting and settlement of Restricted Stock Units.
Following the sale, Prosor directly held 187,573 common shares, and indirectly held 29,286 common shares through Cohen Holdings, LLC, over which she has voting and dispositive control. The transaction represents a routine, tax-related disposition relative to her overall holdings.
Seeley Geoff reported acquisition or exercise transactions in this Form 4 filing.
Lemonade, Inc. director Geoff Seeley reported an equity award in the form of restricted stock units. He received 2,848 shares of common stock at no cash cost as a grant, increasing his direct holdings to 5,967 shares after the transaction.
The award consists of restricted stock units that vest and become exercisable on the earlier of the day immediately preceding the first annual meeting following the grant date or on June 3, 2027. Each unit represents a contingent right to receive one share of Lemonade’s common stock when it vests.